Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (03378)
Founded in 2014, Hansi Aitai Biomedical Technology (Wuhan) Co., Ltd. is an innovative biotechnology company focusing on structural biology, translational medicine and clinical development. The company is committed to developing a new generation of immunotherapies to provide affordable, safe and efficient medical solutions to patients around the world to meet major disease challenges. Adhering to an innovation-driven mis
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
